Cerity Partners
AVNS

Cerity Partners’s Avanos Medical AVNS Stock Holding History

Cerity Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Sell
11,509
-12,796
-53% -$300K ﹤0.01% 2834
2026
Q1 		$341K Buy
24,305
+4,641
+24% +$62.5K ﹤0.01% 2521
2025
Q4 		$221K Sell
19,664
-20,294
-51% -$232K ﹤0.01% 2582
2025
Q3 		$462K Buy
39,958
+17,759
+80% +$208K ﹤0.01% 2025
2025
Q2 		$272K Buy
+22,199
New +$279K ﹤0.01% 2208
2024
Q4 		– Sell
-10,600
Closed -$255K – 2432
2024
Q3 		$255K Buy
+10,600
New +$242K ﹤0.01% 2174
2023
Q2 		– Sell
-421
Closed -$607K – 1661
2023
Q1 		$607K Buy
+421
New +$12.2K ﹤0.01% 1200

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cerity Partners's AVNS Position: Q2 2026 in Review

Cerity Partners reduced its Avanos Medical (AVNS) stake by 53% in Q2 2026, selling an estimated $300K and leaving 11,509 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

Cerity Partners first reported a position in AVNS in Q1 2023 and has held it in 7 quarters since. The position peaked at $607K in Q1 2023. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Cerity Partners held 11,509 shares of Avanos Medical worth $286K as of Q2 2026.
  • Cerity Partners sold 12,796 Avanos Medical shares in Q2 2026, an estimated $300K.
  • Avanos Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2834 holding.
  • Cerity Partners first reported a position in Avanos Medical in Q1 2023 and has held it in 7 quarters since.
  • Cerity Partners's Avanos Medical position peaked at $607K in Q1 2023.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.